As drones survey forests, robots navigate warehouses and sensors monitor city streets, more of the world's decision-making is ...

Eli Lilly is a safer way to capitalize on AI-driven drug discovery.

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Spotify Technology SA will begin testing a new feature that allows users to type an idea for a playlist into the app and receive a unique set of songs based on their historical taste and behavior. The ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Grandfather, 3-month-old granddaughter dead after violent dog attack Opinion: Why Marjorie ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...